Related Experiment Video
Updated: Jul 2, 2026
09:03
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Hepatitis C virus-related arthritis
Carlo Palazzi1, Salvatore D'Angelo, Ignazio Olivieri
1Rheumatology Department of Lucania, San Carlo Hospital of Potenza, Potenza, Italy.
Autoimmunity Reviews
|August 19, 2008
Summary
Hepatitis C virus-related arthritis (HCVrA) presents as symmetrical polyarthritis or intermittent mono-oligoarthritis. Treatment is empirical, with various agents showing partial symptom control, but caution is advised with antiviral therapies.
Area of Science:
- Rheumatology
- Hepatology
- Immunology
Background:
- Chronic hepatitis C virus (HCV) infection frequently causes asymptomatic joint issues.
- True arthritis affects up to 4% of HCV patients, presenting distinct clinical subsets.
- HCV-related arthritis (HCVrA) includes symmetrical polyarthritis (SP) and intermittent mono-oligoarthritis (IMO).
Purpose of the Study:
- To differentiate HCV-related arthritis (HCVrA) subsets.
- To review current treatment strategies for HCVrA.
- To assess the safety and efficacy of various therapeutic options.
Main Methods:
- Literature review of clinical presentations and treatment outcomes for HCVrA.
- Analysis of diagnostic markers, including anti-CCP antibodies for SP differentiation.
- Evaluation of empirical treatment regimens and their effectiveness.
Main Results:
- Symmetrical polyarthritis (SP) resembles rheumatoid arthritis but is less severe.
- Intermittent mono-oligoarthritis (IMO) is linked to mixed cryoglobulinemia and purpura.
- Anti-CCP antibodies aid in distinguishing SP from rheumatoid arthritis.
- Various treatments like NSAIDs, corticosteroids, and methotrexate offer partial symptom control.
- Cyclosporine appears safe, while anti-TNF agents are less favored due to the low-aggressive nature of HCVrA.
Conclusions:
- HCVrA has distinct clinical patterns requiring tailored management.
- Empirical treatments provide variable symptom relief.
- Careful consideration of antiviral therapy is necessary due to potential autoimmune exacerbation.
- Further research is needed to optimize HCVrA treatment protocols.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...